RICERCA ITALIANA     

FIRB simili:

• 1 - ESPRESSIONE GENICA ED ACCUMULO DI PROTEINE D'INTERESSE AGRONOMICO NELLA CELLULA VEGETALE: MECCANISMI TRASCRIZIONALI E POST-TRASCRIZIONALI
• 2 - Meccanismi molecolari della morte cellulare e loro implicazione in patologia umana
• 3 - Approcci combinati di terapia genica nel trattamento del glioblastoma
• 4 - Identificazione ed analisi funzionale delle alterazioni molecolari e geniche che caratterizzano i tumori della mammella ormono-responsivi
• 5 - Il sistema di trasduzione del segnale Ca2+: dalle molecole alle funzioni
• 6 - PROTEASI NELLA RISPOSTA CELLULARE NORMALE E PATOLOGICA: IDENTIFICAZIONE DEI SUBSTRATI ENDOGENI E DEI MECCANISMI MOLECOLARI INDOTTI
• 7 - BILANCIO OSPITE-TUMORE NELLA TERAPIA MEDICA DELLE NEOPLASIE: RUOLO DI NF-kB
• 8 - Metabolismo e organizzazione degli sfingolipidi in modelli di neurodegenerazione cellulare: comprensione dei meccanismi molecolari di base e sviluppo di nuove strategie terapeutiche.
• 9 - Genomica e Proteomica nello studio di funzioni cellulari complesse(GAP).
• 10 - Epigenetica e cromatina

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • GENETICA MEDICA
  • PATOLOGIA CLINICA
  • ONCOLOGIA MEDICA

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)

Classificazione geografica

• Regione: Lombardia

Bibliografia

Amstad PA, Liu H, Ichimiya M, Berezesky IK, Trump BF. Manganese superoxide dismutase expression inhibits soft agar growth in JB6 clone41 mouse epidermal cells. Carcinogenesis 1997, 18, 479.
Anglard P, Brauch TH, Weiss GH, Latif F, Merino MJ, Lerman MI, Zhar B, Linehan WM. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Cancer Res. 1991, 51, 1071.
Anglard P, Trahan E, Liu S, Latif F, Merino MJ, Lerman MI, Zbar B, Lineham WM. Molecular and cellular characterization of human renal cell carcinoma cell. Cancer Res 1992, 52, 348.
Belinsky MG, Bain LJ, Balsara BB, Testa JR, Kruh GD. Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins. J Natl Cancer Inst 1998, 90, 1735.
Belinsky MG, Kruh GD. MOAT-E (ARA) is a full-length MRP/cMOAT subfamily transporter expressed in kidney andliver. Br. J. Cancer 1999, 80, 1342.
Bergerheim U, Nordenskjold M, Collins VP. Deletion mapping in human renal cell carcinoma. Cancer Res. 1990,50, 5531.
Bitter M et al . Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000;406:536-40
Chapman AE, Goldstein LJ.Multiple drug resistance: biologic basic and clinical significance in renal cell carcinoma. Semin Oncol 1995, 22, 17.
Cohen AJ, Li FP, Berg S, Marchetto DJ, Tsai S, Jacobs SC, Brown RS. Hereditary renal cell carcinoma associated with a chromosomal translocation. N. Engl. J. Med. 1979, 301, 592.
Dolo V, et al. Enrichment and localization of ganglioside G(D3) and caveolin-1 in shed tumor cell membrane vesicles. Biochim. Biophys. Acta 2000, 1486, 265.
Ebert T, Bander NH, Finstad CL, Ramsawak RD, Old LJ. Establishment and characterization of human renal cancer and normal kidney cell lines. Cancer Res. 1990, 50, 5531.
Epperly MW, Sikora C, Defilippi S,Bray J, Koe G, Liggitt D, Luketich JD, Greenberger JS. Plasmid/liposome transfer of the human manganese superoxide dismutase transgene prevents ionizing irradiation-induced apoptosis in human esophagus organ explant culture. Int J Cancer 2000, 90, 128.
Epstein CB and Butow RA, Microarray technology-enhanced versatibily, persistent challenge. Curr Opin in Biotechnol 2000;11:36-41
Fiucci G, Czarny M, Lavie Y, Zhao D, Berse B, Blusztajn JK, Liscovitch M, Changes in phospholipase D isoform activity and expression in multidrug-resistant human cancer cells. Int. J. Cancer. 2000, 85, 882.
Fojo AT, Shen DW, Mickley LA, et al. Intrinsic drug resistance in knidey cancer is associated with expression of a human multidrug resistance gene. J Clin Oncol 1987, 5, 1922
Freeman WM et al fundamentals od DNA Hybridization arrays for gene expression analysis, Biotechniques29:1042-1055 (2000)
Ginestra A, Miceli D, Dolo D, Romano FM, Vittorelli ML. Membrane vesicles in ovarian cancer fluids: a potential marker. Anticancer Res. 1999, 19, 3439.
Golub et al. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring, Science 286,531(1999).
Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann. Rev. Biochem. 1993, 62, 385-427.
Hartwell LM., Kastan MB. Cell Cycle Control and Cancer. Science 1994, 266, 1821.
Herbert B. Advances in protein solubilisation for two-dimensional electrophoresis. Electrophoresis 1999, 20, 660-663.
Higuchi R, Focker C, Dollinger G, Watson R. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology, 1993, 11, 1026-1030
Kahn P. From Genome to Proteome: looking at a cell's proteins. Science 1995, 270, 369.
Keough T, Younguist R, Lacey M. Proc. Natl. Acad. Sci. USA, 1999, 96, 7131.
Kim WJ, Kakehi Y, Kinoshita H, Arao S, Fukumoto M, Yoshida O. Expression patterns of multidrug-resistance (MDR1), multidrug resistance-associated protein (MRP), glutathione-s-transferase-p (GST-p) and DNA topoisomerase II (Topo II) genes in renal cell carcinomas and normal kidney. J Urology 1996, 156,506.
Kiningham KK, Oberley TD, Lin SM, Mattingly CA, St. Clair DK. Overexpression of manganese superoxide dismutase protects against mitochondrial-initiated poly(ADP-ribose) polymerase-mediated cell death. FASEB J. 1999, 13, 1601.
Lee SW. Reimer CL. Oh P. Campbell DB. Schnitzer JE. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 1999, 16, 1391.
Moch et al. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in Renal Cell Carcinoma,Am J. Pathol.154 (4) 981-986
Racine C. Belanger M. Hirabayashi H. Boucher M. Chakir J. Couet J Reduction of caveolin 1 gene expression in lung carcinoma cell lines. Biochem. Biophys. Res. Comm. 1999, 255, 580.
Sarto C, Frutiger S, Cappellano F, Sanchez JC, Doro G, Catanzaro F, Hughes G, Hochstrasser DF, Mocarelli P. Modified expression of plasma glutathione peroxidase and manganese superoxide dismutase in human renal cell carcinoma. Electrophoresis 1999, 20, 3458.
Sarto C, Marocchi A, Sanchez JC, Giannone D, Frutiger S, Golaz O, Wilkins MR, Doro G, Cappellano F, Hughes G, Hochstrasser DF, Mocarelli P. Renal cell carcinoma and normal kidney protein expression. Electrophoresis 1997, 18, 599.
Schleuder D, Hillenkamp F, Strupat K. Anal. Chem., 1999, 71, 3238.
Scott RE, Furcht LT. Membrane pathology of normal and malignant cells--a review. Human Pathol. 1976, 7, 519.
Someren A, Zantari GS, Campbell J, Parrott T, White J,Baumgartner BR, Atkinson GO, Graham J, Woodard JR, Chezman JL, Wyly JB, Fekete PS, Hertzler G. The kidneys. In: Urologic Pathology with Clinical and Radiologyc Correlations. Ed Someren A. New York: MacMillan Publishing Company, 1989, pp172-201.
Steinman H. Superoxide dismutase: protein chemistry and structure-function relationships. In Superoxide Dismutase. Ed Oberley L. CRC Press. Boca R, Fl. A, Juniki A, Shiro A, Yoshihiro T,Susumu K, Yoshio H. Overexpression of Manganese Superoxide Dismutase gene suppresses spontaneous apoptosis without a resultant alteration in in vivo growth of the mouse fibrosarcoma, FSa-II. Anticancer Res. 2000, 20, 7.
Taylor DD, Black PH, Shedding of plasma membrane fragments. Neoplastic and developmental importance. Dev. Biol. 1986, 3, 33.
Volm M, Pommerenke EW, Efferth T, Lohrke H, Mattern J. Circumvention of multi-drug resistance in human kidney and kidney carcinoma in vitro. Cancer 1991,67, 2484.
Waterston R, SulstonJ: the human genome project: reaching the finish line.Science 1998,282:55-57
De Risi et al Use a cDNA microarray to analyse gene expression patterns in human cancer Nat Genet 1996,14;457-460
Wellmann A et al Detection of differential expressed in lymphomas using cDNA arrays: identification of clusterin as a new marksr for annnaplastic large -cell lymphomas, Blood,2000(96) sect 1734: 398-404
Celis JE et al Gene expression profiling: monitoring transcriptional and traslation products using DNA microarrays and proteomics. FEBS Letters 480 (2000) 2-16
Wilkins MR, Sanchez JC, Gooley AA, Appel RD, Humphery-Smith I, Hochstrasser DF, Williams KL Progress with proteome project: why all proteins expressed by a genome should be identified and how to do it. Biotechnol Gene Eng Rev 1995, 13, 19.
Wilkins MR, Williams KL, Hochstrasser DF in Proteome Research: New Frontiers in Functional Genomics, 1997, Springer, Berlin.
Wingo PA, Tong T, Bolden S. Cancer statistics. CA 1995, 45, 8.
Wunderlich H, Schlichter A, Kosmehl H, Shubert J.. The histopathological heterogeniceity of small renal cell carcinoma. Anticancer Res 1999, 19, 1497-1500.
Yang G, et al.. Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker. Cancer Res. 1999, 5957, 19.

Parole Chiave

carcinoma renale; proteoma; elettroforesi bidimensionale; spettrometria di massa; microdissezione a cattura laser; DNA microarray